热门资讯> 正文
索诺玛和电磁兼容将共同营销扩大的眼部护理产品线
2024-09-11 21:01
- Sonoma Pharmaceuticals (NASDAQ:SNOA) said on Wednesday it has entered into a co-marketing agreement with EMC Pharma to launch and sell an expanded prescription and OTC eye care product line.
- Sonoma (SNOA) and EMC Pharma entered into a distribution agreement in 2021, granting EMC Pharma the exclusive right to manage, market and distribute Sonoma's HOCl-based prescription dermatology and eye care products in the United States.
- EMC Pharma will now additionally have the right to sell over-the-counter Ocucyn, and Sonoma will have the right to sell Acuicyn eyelid & eyelash cleanser.
More on Sonoma Pharmaceuticals
- Sonoma Pharmaceuticals reports Q1 results
- Seeking Alpha’s Quant Rating on Sonoma Pharmaceuticals
- Historical earnings data for Sonoma Pharmaceuticals
- Financial information for Sonoma Pharmaceuticals
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
